SCHEMBL6470232

SCHEMBL6470232

CNC(=O)c1ccc(-c2ccc(-n3cc(NC(N)=O)c(C(N)=O)n3)cc2)cc1F

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5AP P20292 3/20 0.41
ALOX5 P09917 2/20 0.41
FEN1 P39748 2/20 0.41
CYP3A4 P08684 1/20 0.40
PARP1 P09874 3/20 0.40
IRAK4 Q9NWZ3 2/20 0.39
ITK Q08881 1/20 0.39
KIF11 P52732 3/20 0.39
MET P08581 3/20 0.39
KCNH2 Q12809 1/20 0.37
KDM4E B2RXH2 2/20 0.37
MAPT P10636 2/20 0.37
NPC1 O15118 1/20 0.37
ALDH1A1 P00352 1/20 0.37
TP53 P04637 1/20 0.37
ALOX15 P16050 1/20 0.37
MAPK1 P28482 1/20 0.37
RAB9A P51151 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
HSD17B10 Q99714 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6467616 0.91 KIF11 (0.43) ALOX5APALOX5FEN1CYP3A4PARP1
SCHEMBL6504083 0.89 AXL (0.41) ALOX5APALOX5FEN1CYP3A4PARP1
SCHEMBL6467657 0.87 KMT2A (0.44) PARP1ALDH1A1MAPK1
SCHEMBL6507842 0.86 IDO1 (0.45) PARP1ITKKIF11KDM4EMAPT
SCHEMBL6477607 0.86 HDAC1 (0.42) PARP1METKDM4EMAPTALDH1A1
SCHEMBL6467963 0.86 LMNA (0.42) PARP1METMAPTALDH1A1TP53
SCHEMBL6470160 0.84 HDAC1 (0.43) PARP1MAPTNPC1TP53MAPK1
SCHEMBL6505259 0.84 KDM4E (0.44) PARP1IRAK4ITKKDM4EMAPT
SCHEMBL6470445 0.84 CDC7 (0.46) METMAPTTP53MAPK1
SCHEMBL6504428 0.83 PDE10A (0.44) KDM4EMAPTALDH1A1TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050197338-A1 Substituted pyrazole urea compounds for the treatment of inflammation PHARMACIA AND UPJOHN COMPANY LLC 2005-09-08 US disclosed
WO-2005037797-A1 SUBSTITUTED PYRAZOLE UREA COMPOUNDS FOR THE TREATMENT OF INFLAMMATION PHARMACIA CORPORATION (US) 2005-04-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050197338-A1 Substituted pyrazole urea compounds for the treatment of inflammation IL4, ARG2, CASP4 ALOX5AP 3501/4885ALOX5 2489/4885FEN1 3536/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.